Company facts
- Industry
- Services-Medical Laboratories
- Headquarters
- Durham, North Carolina
- Most recent report
- 10-Q, filed Oct 29, 2026
- Incorporated
- N/A
- Filings on record
- 338 filings
- On EDGAR
- CIK 1965040
- Fiscal year ends
- December
- Filer status
- Accelerated filer
Financials 8 of 14
News 8 of 47
Prospectuses and Registrations 3
Proxies 7
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEFA14A Extra proxy material May 15, 2025
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Mar 28, 2024
- DEF 14A Proxy statement for a shareholder vote Mar 28, 2024
Ownership 8 of 245
- 4 Insider reported a trade Sep 14, 2026
- 144/A Notice of a proposed sale of restricted stock, amended Sep 11, 2026
- 144 Notice of a proposed sale of restricted stock Sep 11, 2026
- 4 Insider reported a trade Sep 10, 2026
- 4 Insider reported a trade Sep 10, 2026
- 144 Notice of a proposed sale of restricted stock Sep 10, 2026
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
Other 8 of 22
- ARS Annual report sent to shareholders Apr 27, 2026
- 8-A12B Registration of a security for exchange listing Jun 12, 2025
- ARS Annual report sent to shareholders Apr 28, 2025
- NT 10-Q Notice that a quarterly report will be late May 15, 2024
- ARS Annual report sent to shareholders Mar 28, 2024
- SEC STAFF ACTION Jun 9, 2023
- CERT Exchange certified a listing Jun 9, 2023
- CORRESP Reply to SEC staff Jun 8, 2023
Everything here comes from Fortrea Holdings Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.